Loading…
Leica Biosystems and Sectra announced a collaboration to seek a combined 510(k) clearance from the FDA for an integrated clinical digital pathology solution.
Leica Biosystems GmbH is investing six million euros in its Nußloch site, expanding production to include medical blades by 2024.
Leica Biosystems and KUB Technologies have announced a new global distribution agreement for Kubtec's specimen imaging systems, including the XPERT and MOZART systems for breast imaging and pathology. The agreement includes exclusive distribution of the co-branded Mammotome Confirm system in the US and worldwide.
| Site | Largest | Latest |
|---|---|---|
| Nußloch, Germany | $6.80M | 2019-01-15 |